IGC Pharma, Inc. (IGC) (CIK 0001326205) CORRESP

IGC Pharma, Inc. (IGC) (CIK 0001326205) → SEC staff · filed 2025-12-04 · ticker IGC · SIC 2834 · view PDF on sec.gov ↗
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

Key facts

Accession number
0001185185-25-001921
Form
CORRESP
Filer
IGC Pharma, Inc. (IGC) (CIK 0001326205)
CIK
0001326205
Ticker
IGC
Filed
2025-12-04
SIC industry
2834
HQ
Potomac, MD

Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1326205/000118518525001921/filename1.htm

EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗